Panacea Biotec Ltd
NSE:PANACEABIO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
119.05
393.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Panacea Biotec Ltd
Panacea Biotec Ltd
Total Current Liabilities
Panacea Biotec Ltd
Total Current Liabilities Peer Comparison
524663
526139
HESTERBIO
BIOCON
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Total Current Liabilities
₹3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Total Current Liabilities
₹990.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Transgene Biotek Ltd
BSE:526139
|
Total Current Liabilities
₹111.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Total Current Liabilities
₹135.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-15%
|
|
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Total Current Liabilities
₹1.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Biocon Ltd
NSE:BIOCON
|
Total Current Liabilities
₹153.6B
|
CAGR 3-Years
56%
|
CAGR 5-Years
36%
|
CAGR 10-Years
27%
|
See Also
What is Panacea Biotec Ltd's Total Current Liabilities?
Total Current Liabilities
3.1B
INR
Based on the financial report for Jun 30, 2024, Panacea Biotec Ltd's Total Current Liabilities amounts to 3.1B INR.
What is Panacea Biotec Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
-12%
Over the last year, the Total Current Liabilities growth was -7%. The average annual Total Current Liabilities growth rates for Panacea Biotec Ltd have been -12% over the past three years .
You don't have any saved screeners yet
